| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2119 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1501 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1176 | 2008 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 287 | 2005 |
| A large French prospective cohort of HIV‐infected patients: the Nadis Cohort P Pugliese, L Cuzin, A Cabié, I Poizot‐Martin, C Allavena, C Duvivier, ... HIV medicine 10 (8), 504-511, 2009 | 129 | 2009 |
| Risk factors of chronic kidney disease in HIV-infected patients P Flandre, P Pugliese, L Cuzin, CI Bagnis, I Tack, A Cabié, I Poizot-Martin, ... Clinical Journal of the American Society of Nephrology 6 (7), 1700-1707, 2011 | 121 | 2011 |
| Non-AIDS defining cancers in the D: A: D Study-time trends and predictors of survival: a cohort study SW Worm, M Bower, P Reiss, F Bonnet, M Law, G Fätkenheuer, ... BMC infectious diseases 13, 1-15, 2013 | 100 | 2013 |
| Outcome of patients treated with home enteral nutrition SM Schneider, C Raina, P Pugliese, I Pouget, P Rampal, X Hébuterne Journal of Parenteral and Enteral Nutrition 25 (4), 203-209, 2001 | 97 | 2001 |
| Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs Study Group Clinical infectious diseases 46 (7), 1101-1110, 2008 | 84 | 2008 |
| Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation FX Caroli-Bosc, PL Gall, P Pugliese, B Delabre, C Caroli-Bosc, ... Digestive diseases and sciences 46, 540-544, 2001 | 80 | 2001 |
| Antiretroviral exposure and comorbidities in an aging HIV-infected population: the challenge of geriatric patients C Allavena, M Hanf, D Rey, C Duvivier, F BaniSadr, I Poizot-Martin, ... PloS one 13 (9), e0203895, 2018 | 75 | 2018 |
| Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries HIV-CAUSAL Collaborationa Clinical Infectious Diseases 54 (9), 1364-1372, 2012 | 75 | 2012 |
| Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV P Pradat, T Huleux, F Raffi, P Delobel, MA Valantin, I Poizot-Martin, ... Aids 32 (8), 1077-1082, 2018 | 66 | 2018 |
| Prevalence of and factors associated with depression among people living with HIV in France P Feuillet, F Lert, L Tron, C Aubriere, B Spire, R Dray‐Spira, ... HIV medicine 18 (6), 383-394, 2017 | 65 | 2017 |
| Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study. P Gantner, L Cuzin, C Allavena, A Cabie, P Pugliese, MA Valantin, ... HIV medicine 18 (9), 704-708, 2017 | 61 | 2017 |
| Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study A Makinson, JC Tenon, S Eymard-Duvernay, JL Pujol, C Allavena, ... Journal of Thoracic Oncology 6 (6), 1022-1029, 2011 | 59 | 2011 |
| Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort L Cuzin, P Pugliese, C Katlama, F Bani-Sadr, T Ferry, D Rey, J Lourenco, ... Journal of Antimicrobial Chemotherapy 74 (3), 754-760, 2019 | 58 | 2019 |
| Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men L Cotte, E Cua, J Reynes, F Raffi, D Rey, P Delobel, A Gagneux‐Brunon, ... Liver International 38 (10), 1736-1740, 2018 | 58 | 2018 |
| The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study HIV-Causal Collaboration Aids 26 (13), 1691-1705, 2012 | 57 | 2012 |
| COPD in HIV-infected patients: CD4 cell count highly correlated K Risso, F Guillouet-de-Salvador, L Valerio, P Puglièse, A Naqvi, J Durant, ... PloS one 12 (1), e0169359, 2017 | 53 | 2017 |
